Literature DB >> 17053524

Cardiovascular disease, metabolic syndrome and erectile dysfunction.

Alexander Müller1, John P Mulhall.   

Abstract

PURPOSE OF REVIEW: Erectile dysfunction and cardiovascular disease share the same risk factors such as hypertension, diabetes, dyslipidemia, obesity, and smoking, all of which are implicated in causing endothelial dysfunction. In this review, an overview is given on the role of endothelium in the pathophysiology of erectile dysfunction, cardiovascular disease, and the metabolic syndrome as well as the links between them. RECENT
FINDINGS: Current literature offers strong evidence that endothelial dysfunction and erectile dysfunction are linked. Erectile dysfunction appears to be one of the earliest signs of systemic vascular disease and might be considered as an early marker for subclinical cardiovascular disease. Obesity is one of the many risk factors for cardiovascular disease and is also associated with hypertension, dyslipidemia, glucose intolerance, and insulin resistance, which together define the metabolic syndrome. Experimental, clinical, and epidemiologic studies support the association between metabolic syndrome and cardiovascular disease.
SUMMARY: The above-mentioned risk factors are a potential threat to the penile endothelium and the smooth muscle tissue leading to functional and structural changes. These important pathophysiologic factors are the foundation for the strong link between erectile dysfunction and cardiovascular disease. Recent literature supports the link between metabolic syndrome and erectile dysfunction and highlights metabolic syndrome as a potential risk factor for the development of erectile dysfunction.

Entities:  

Mesh:

Year:  2006        PMID: 17053524     DOI: 10.1097/01.mou.0000250284.83108.a6

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  20 in total

1.  Identifying risk factors for metabolic syndrome in biomedical text.

Authors:  Marcelo Fiszman; Graciela Rosemblat; Caroline B Ahlers; Thomas C Rindflesch
Journal:  AMIA Annu Symp Proc       Date:  2007-10-11

2.  Impact of metabolic syndrome on stress urinary incontinence in pre- and postmenopausal women.

Authors:  Alper Otunctemur; Murat Dursun; Emin Ozbek; Suleyman Sahin; Huseyin Besiroglu; Ismail Koklu; Mustafa Erkoc; Eyyup Danis; Muammer Bozkurt
Journal:  Int Urol Nephrol       Date:  2014-03-04       Impact factor: 2.370

3.  Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction.

Authors:  Hicham Labazi; Brandi M Wynne; Rita Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2013-07-24       Impact factor: 3.802

4.  The correlation between high sensitivity C-reactive protein and erectile dysfunction patients with hypertension treated with vardenafil.

Authors:  S Azab; H Aoud; N Nabil
Journal:  Int J Impot Res       Date:  2016-12-01       Impact factor: 2.896

5.  The impact of metabolic syndrome on retinal findings in patients with erectile dysfunction.

Authors:  Melih Balcı; Yılmaz Aslan; Berçem Bozarslan; Altuğ Tuncel; Mustafa Kayalı; Ali Atan
Journal:  Turk J Urol       Date:  2013-03

6.  Erectile dysfunction may be the first clinical sign of insulin resistance and endothelial dysfunction in young men.

Authors:  Fengjuan Yao; Lijuan Liu; Yan Zhang; Yanping Huang; Donghong Liu; Hong Lin; Yanqiu Liu; Rui Fan; Cuiling Li; Chunhua Deng
Journal:  Clin Res Cardiol       Date:  2013-05-17       Impact factor: 5.460

Review 7.  The role of opiorphins (endogenous neutral endopeptidase inhibitors) in urogenital smooth muscle biology.

Authors:  Kelvin Paul Davies
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

8.  TNF-alpha infusion impairs corpora cavernosa reactivity.

Authors:  Fernando S Carneiro; Saiprazad Zemse; Fernanda R C Giachini; Zidonia N Carneiro; Victor V Lima; R Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

9.  DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum.

Authors:  Fernando S Carneiro; Fernanda R C Giachini; Victor V Lima; Zidonia N Carneiro; Kênia P Nunes; Adviye Ergul; Romulo Leite; Rita C Tostes; R Clinton Webb
Journal:  Can J Physiol Pharmacol       Date:  2008-06       Impact factor: 2.273

10.  hSMR3A as a marker for patients with erectile dysfunction.

Authors:  Yuehong Tong; Moses Tar; Val Monrose; Michael DiSanto; Arnold Melman; Kelvin P Davies
Journal:  J Urol       Date:  2007-05-23       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.